T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued to investors on Tuesday morning. The firm issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

Shares of NASDAQ TTOO opened at $0.12 on Tuesday. T2 Biosystems has a twelve month low of $0.06 and a twelve month high of $6.80. The stock’s 50 day moving average price is $0.19 and its 200-day moving average price is $0.82.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.